Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database

(1) Background: The duration of adjuvant chemotherapy recommended by the NCCN guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy for many reasons; therefore, one approach is to obtain a survival benefit by prolonging the duration of capecitabine monotherapy. (2...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qiao Yu, Zhigui Li, Yuqing Liu, Yichen Luo, Jingya Fan, Peijun Xie, Xiaoman Cao, Xingyu Chen, Xiaodong Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-01-01
coleção:	Current Oncology
Assuntos:	capecitabine monotherapy colorectal cancer adjuvant chemotherapy
Acesso em linha:	https://www.mdpi.com/1718-7729/30/1/72
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!